TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes in kidney disease patients

A study examining outcomes between different carotid revascularization procedures has concluded that transcarotid artery revascularization (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable choice” in severe chronic kidney disease (CKD) and hemodialysis patients—but transfemoral carotid artery stenting (TF-CAS) appears…
Pushing the boundaries of vascular care: VQI meeting kicks off at VAM

The Vascular Quality Initiative (VQI) is hosting its two-day annual conference at the 2024 Vascular Annual Meeting (VAM 2024) from June 18–19, drawing healthcare professionals dedicated to advancing the quality and safety of vascular care. This event, organized with the…
New data underscore physician experience levels required to derive benefit from transfemoral carotid artery stenting

Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on depth of physician experience with the procedure represent an “absolute minimum threshold of learning,” the lead…
As temporal trends in hemodialysis access creation emerge, notion of AV fistula superiority comes under scrutiny

The 2024 Southern Association for Vascular Surgery (SAVS) annual meeting (Jan. 24–27) hears three separate talks—two scientific papers and one from an invited guest lecturer—that separately and from different angles checked the pulse of the arteriovenous fistula (AVF)-first era. Sandwiched…
SVS points to 2023 achievements, challenges in coming year

The Society for Vascular Surgery (SVS) reflects on a year marked by notable achievements on multiple fronts. In a communication to members in mid-December, Executive Director, Kenneth M. Slaw, PhD, underscored the organization’s growth, collaborative endeavors and key milestones attained…
SVS members pitch in to help patients kick the smoking habit

SVS members are taking advantage of the new Smoking Cessation Toolkit and resources from the Vascular Quality Initiative (VQI), adding them to existing programs and giving new life to their quest to get their patients to kick the nicotine habit…
Changing course: The natural history of tibial claudication comes under scrutiny as interventions for ‘relatively benign’ disease trend upward

In the end, reflected Michael S. Conte, MD, “it’s not the evidence.” The leading vascular surgeon and peripheral arterial disease (PAD) expert made the bold statement during the recent 2023 VEITHsymposium (Nov. 14–18) as he pointedly asked a room full…
SVS launches national smoking cessation initiative

The Society for Vascular Surgery’s Patient Safety Organization (SVS PSO) has formally launched a national smoking cessation initiative. It includes tools and resources to help physicians, surgeons and other healthcare professionals to help their patients kick the smoking habit. CAN-DO (Choosing Against…
VQI Fellows in Training program marks one year

The Vascular Quality Initiative (VQI) Fellows in Training (FIT) program is a success, said leaders as they provided a one-year review. FIT introduces residents and fellows in vascular surgery and medicine to the SVS Patient Safety Organization (PSO). Fellows worked…
VAM 2023: Vascular Quality Initiative launches national smoking cessation drive

The SVS Patient Safety Organization (SVS PSO) has launched a national smoking cessation initiative. SVS PSO Associate Medical Director Gary Lemmon, MD, and SVS PSO Director of Quality Betsy Wymer introduced the program during SVS PSO’s Vascular Quality Initiative’s (VQI)…

